Literature DB >> 21576334

Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.

Michael A Bachman1, Jennifer E Oyler, Samuel H Burns, Mélissa Caza, François Lépine, Charles M Dozois, Jeffrey N Weiser.   

Abstract

Klebsiella pneumoniae is a pathogen of increasing concern because of multidrug resistance, especially due to K. pneumoniae carbapenemases (KPCs). K. pneumoniae must acquire iron to replicate, and it utilizes iron-scavenging siderophores, such as enterobactin (Ent). The innate immune protein lipocalin 2 (Lcn2) is able to specifically bind Ent and disrupt iron acquisition. To determine whether K. pneumoniae must produce Lcn2-resistant siderophores to cause disease, we examined siderophore production by clinical isolates (n = 129) from respiratory, urine, blood, and stool samples and by defined siderophore mutants through genotyping and liquid chromatography-mass spectrometry. Three categories of K. pneumoniae isolates were identified: enterobactin positive (Ent(+)) (81%), enterobactin and yersiniabactin positive (Ent(+) Ybt(+)) (17%), and enterobactin and salmochelin (glycosylated Ent) positive (Ent(+) gly-Ent(+)) with or without Ybt (2%). Ent(+) Ybt(+) strains were significantly overrepresented among respiratory tract isolates (P = 0.0068) and β-lactam-resistant isolates (P = 0.0019), including the epidemic KPC-producing clone multilocus sequence type 258 (ST258). In ex vivo growth assays, gly-Ent but not Ybt allowed evasion of Lcn2 in human serum, whereas siderophores were dispensable for growth in human urine. In a murine pneumonia model, an Ent(+) strain was an opportunistic pathogen that was completely inhibited by Lcn2 but caused severe, disseminated disease in Lcn2(-/-) mice. In contrast, an Ent(+) Ybt(+) strain was a frank respiratory pathogen, causing pneumonia despite Lcn2. However, Lcn2 retained partial protection against disseminated disease. In summary, Ybt is a virulence factor that is prevalent among KPC-producing K. pneumoniae isolates and promotes respiratory tract infections through evasion of Lcn2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576334      PMCID: PMC3147564          DOI: 10.1128/IAI.05114-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Occurrence of the Yersinia high-pathogenicity island and iron uptake systems in clinical isolates of Klebsiella pneumoniae.

Authors:  Ryszard Koczura; Adam Kaznowski
Journal:  Microb Pathog       Date:  2003-11       Impact factor: 3.738

2.  An iron delivery pathway mediated by a lipocalin.

Authors:  Jun Yang; David Goetz; Jau Yi Li; Wenge Wang; Kiyoshi Mori; Daria Setlik; Tonggong Du; Hediye Erdjument-Bromage; Paul Tempst; Roland Strong; Jonathan Barasch
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

3.  Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis.

Authors:  S W Bearden; J D Fetherston; R D Perry
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Rapid detection of Salmonella enterica with primers specific for iroB.

Authors:  A J Bäumler; F Heffron; R Reissbrodt
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

Review 5.  Klebsiella bacteremia: an analysis of 100 episodes.

Authors:  M García de la Torre; J Romero-Vivas; J Martínez-Beltrán; A Guerrero; M Meseguer; E Bouza
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

6.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.

Authors:  L Kjeldsen; A H Johnsen; H Sengeløv; N Borregaard
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

Review 7.  Iron uptake mechanisms of pathogenic bacteria.

Authors:  K G Wooldridge; P H Williams
Journal:  FEMS Microbiol Rev       Date:  1993-11       Impact factor: 16.408

8.  Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.

Authors:  L Landrø; J K Damås; T H Flo; L Heggelund; T Ueland; G E Tjønnfjord; T Espevik; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

9.  Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils.

Authors:  J R Bundgaard; H Sengeløv; N Borregaard; L Kjeldsen
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

10.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  110 in total

1.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 3.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia.

Authors:  Thouraya Chérif; Mabrouka Saidani; Dominique Decré; Ilhem Boutiba-Ben Boubaker; Guillaume Arlet
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

5.  KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen.

Authors:  L S Tzouvelekis; V Miriagou; S D Kotsakis; K Spyridopoulou; E Athanasiou; E Karagouni; E Tzelepi; G L Daikos
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

6.  Emergence of an NDM-5-Producing Hypervirulent Klebsiella pneumoniae Sequence Type 35 Strain with Chromosomal Integration of an Integrative and Conjugative Element, ICEKp1.

Authors:  Zhen Shen; Qianqian Gao; Juanxiu Qin; Yao Liu; Min Li
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

7.  Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells.

Authors:  Victoria I Holden; Steven Lenio; Rork Kuick; Sadeesh K Ramakrishnan; Yatrik M Shah; Michael A Bachman
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

8.  Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Blandina T Mmbaga; Ole Lund; Gibson S Kibiki; Frank M Aarestrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-20       Impact factor: 3.267

Review 9.  The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.

Authors:  Kimberly A Walker; Virginia L Miller
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

10.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.